Edition:
United States

Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

11.90SEK
20 Jan 2017
Change (% chg)

0.20kr (+1.71%)
Prev Close
11.70kr
Open
12.00kr
Day's High
12.00kr
Day's Low
11.55kr
Volume
70,279
Avg. Vol
86,713
52-wk High
15.24kr
52-wk Low
7.37kr

Select another date:

Mon, Jan 9 2017

BRIEF-Active Biotech says receives European patent for tasquinimod

* Says the European Patent Office grants patent for tasquinimod for treatment of multiple myeloma

BRIEF-Active Biotech to raise SEK 55 mln via rights issue

* Active biotech carries out rights issue of approximately 55 million Swedish crowns ($6.03 million)

BRIEF-Active Biotech Q3 loss narrows

* Cash and cash equivalents at the end of the period SEK 39.9 million Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

BRIEF-Active Biotech partners with NeoTX for commercialization of ANYARA

* Reg-Active Biotech and NeoTX enter into a partnership for the development and commercialization of ANYARA for immuno-oncology

BRIEF-Active Biotech postpones publication of interim report

* Reg-Active Biotech postpone publication of the interim report

BRIEF-Active Biotech updates on laquinimod development

* Active Biotech update on laquinimod development: U.S, Food and Drug Administration rescinds special protocol assessment for laquinimod Source text for Eikon: Further company coverage:

Select another date: